Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$5.08 USD
+0.67 (15.19%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $5.15 +0.07 (1.38%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Earnings News For CAPR
-
Capricor Therapeutics (CAPR) Reports Q2 Loss, Misses Revenue Estimates
-
Capricor: Q2 Earnings Snapshot
-
Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Capricor: Q1 Earnings Snapshot
-
Capricor Therapeutics (CAPR) Reports Q1 Loss, Misses Revenue Estimates
-
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Capricor: Q4 Earnings Snapshot
-
Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
Capricor: Q3 Earnings Snapshot
-
Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
Earnings Preview: Capricor Therapeutics (CAPR) Q3 Earnings Expected to Decline
-
Capricor: Q2 Earnings Snapshot
-
Capricor Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
Capricor: Q1 Earnings Snapshot
-
Capricor Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
-
Capricor: Q4 Earnings Snapshot
-
Capricor Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
-
Capricor Therapeutics (CAPR) Reports Q3 Loss, Tops Revenue Estimates
-
Capricor: Q3 Earnings Snapshot
-
Capricor Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Capricor: Q2 Earnings Snapshot
-
Capricor Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
Capricor Therapeutics (CAPR) Reports Q3 Loss, Lags Revenue Estimates
-
Capricor Therapeutics (CAPR) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
-
Capricor Therapeutics (CAPR) Reports Q1 Loss, Lags Revenue Estimates